Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:100 (12 January), doi:10.1136/bmj.39454.622824.94
Des Spence, general practitioner, Glasgow
destwo@yahoo.co.uk
| The first 150 words of the full text of this article appear below. |
In my shabby and stained white coat, I twirled my thick gelled fringe. He sat in a crisp, double breasted, pin striped suit, nursing a leather FiloFax and flipping through the glossy charts showing pension growth. I nodded confidently to cover my bewilderment at his sales pitch. Twenty minutes later he crushed my hand and left, with my signature on a monthly investment. Five years later I scratched my now shaven head in bewilderment at the evaluation quote of £67. I complained about mis-selling to the financial ombudsman and vowed never to be fooled or confused by an "expert" or by numbers again.
Whether its worth treating high cholesterol is a common enough question. No one who sees the charts and listens to the sales pitch would doubt it—but numbers are open to being spun. Lets consider the trial known as WOSCOPS—the west of Scotland coronary prevention study (New
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.